The WACC of Supernus Pharmaceuticals Inc (SUPN) is 7.6%.
Range | Selected | |
Cost of equity | 7.70% - 9.80% | 8.75% |
Tax rate | 22.30% - 23.90% | 23.10% |
Cost of debt | 4.00% - 4.90% | 4.45% |
WACC | 6.7% - 8.5% | 7.6% |
Category | Low | High |
Long-term bond rate | 4.2% | 4.7% |
Equity market risk premium | 5.0% | 6.0% |
Adjusted beta | 0.7 | 0.77 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 7.70% | 9.80% |
Tax rate | 22.30% | 23.90% |
Debt/Equity ratio | 0.27 | 0.27 |
Cost of debt | 4.00% | 4.90% |
After-tax WACC | 6.7% | 8.5% |
Selected WACC | 7.6% | |